XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 100.5 $ 141.8
Trade and other accounts receivable (less allowances of $8.9 million and $5.1 million respectively) 342.5 284.5
Inventories (less allowances of $26.3 million and $25.4 million respectively):    
Finished goods 266.9 188.3
Raw materials 114.9 89.3
Total inventories 381.8 277.6
Prepaid expenses 7.4 18.0
Prepaid income taxes 13.8 5.8
Other current assets 0.4 0.4
Total current assets 846.4 728.1
Net property, plant and equipment 206.6 214.4
Operating lease right-of-use assets 45.9 35.4
Goodwill 351.7 364.3
Other intangible assets 43.6 57.5
Deferred tax assets 5.7 6.4
Pension asset 162.7 159.8
Other non-current assets 6.6 5.0
Total assets 1,669.2 1,570.9
Current liabilities:    
Accounts payable 173.6 148.7
Accrued liabilities 173.9 166.5
Finance leases   0.1
Current portion of operating lease liabilities 13.6 12.4
Current portion of plant closure provisions 5.6 5.2
Current portion of accrued income taxes 14.7 3.7
Total current liabilities 381.4 336.6
Operating lease liabilities, net of current portion 32.1 23.1
Plant closure provisions, net of current portion 50.0 51.3
Accrued income taxes, net of current portion 20.8 30.6
Unrecognized tax benefits 16.3 16.3
Deferred tax liabilities 59.7 60.8
Pension liabilities and post-employment benefits 15.6 17.8
Other non-current liabilities 1.4 1.4
Total liabilities 577.3 537.9
Equity:    
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares 0.3 0.3
Additional paid-in capital 352.2 346.7
Treasury stock (4,781,326 and 4,780,806 shares at cost, respectively) (94.6) (90.6)
Retained earnings 914.8 822.9
Accumulated other comprehensive loss (83.3) (46.9)
Total Innospec stockholders' equity 1,089.4 1,032.4
Non-controlling interest 2.5 0.6
Total equity 1,091.9 1,033.0
Total liabilities and equity $ 1,669.2 $ 1,570.9